Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of amino acid metabolism (HP:0004337)help
Parent Node:
expand
Abnormal circulating glutamine family amino acid concentration (HP:0010902)help
..Starting node
..expand
Abnormal circulating proline concentration (HP:0010907)help
Term ID: 10907
Name: Abnormal circulating proline concentration
Synonym:
Definition: Any deviation from the normal concentration of proline or a proline metabolite in the blood circulation.
Comments:
Reference: HP:0010907
Genes and Diseases:
 
       Child Nodes:
........expandHydroxyprolinuria (HP:0003080) help
........expandProlinuria (HP:0003137) help
........expandHydroxyprolinemia (HP:0003260) help
........expandHyperprolinemia (HP:0008358) help
........expandIncreased level of L-pyroglutamic acid in urine (HP:0410132) help

 Sister Nodes: 
..expandAbnormal circulating arginine concentration (HP:0010909) help
..expandAbnormal circulating glutamine concentration (HP:0010903) help
..expandIncreased level of L-glutamic acid in blood (HP:0410068) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010907HP:0010907Abnormal circulating proline concentration0ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 274
HP:0010907HP:0010907Abnormal circulating proline concentration0ALDH4A1 CL E G H8659406OMIM:239510Hyperprolinemia, type II74
HP:0010907HP:0010907Abnormal circulating proline concentration0COX10 CL E G H13522260OMIM:619046MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN382
HP:0010907HP:0010907Abnormal circulating proline concentration0COX16 CL E G H5124120213OMIM:619355MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22
HP:0010907HP:0010907Abnormal circulating proline concentration0COX5A CL E G H93772267OMIM:619064MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20
HP:0010907HP:0010907Abnormal circulating proline concentration0LIPT1 CL E G H5160129569OMIM:616299Lipoyltransferase 1 deficiency21
HP:0010907HP:0010907Abnormal circulating proline concentration0NDUFB10 CL E G H47167696OMIM:619003MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35; MC1DN35
HP:0010907HP:0010907Abnormal circulating proline concentration0NDUFC2 CL E G H47187706OMIM:619170MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36
HP:0010907HP:0010907Abnormal circulating proline concentration0PDP1 CL E G H547049279ORPHA:79246Pyruvate dehydrogenase phosphatase deficiency52
HP:0010907HP:0010907Abnormal circulating proline concentration0PRODH CL E G H56259453ORPHA:419Hyperprolinemia type 113
HP:0010907HP:0010907Abnormal circulating proline concentration0PRODH CL E G H56259453OMIM:239500Hyperprolinemia, type I13
HP:0010907HP:0010907Abnormal circulating proline concentration0PRODH CL E G H56259453OMIM:600850Schizophrenia 413
HP:0010907HP:0010907Abnormal circulating proline concentration0SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intolerance104
HP:0010907HP:0010907Abnormal circulating proline concentration0TARS2 CL E G H8022230740OMIM:615918Combined oxidative phosphorylation deficiency 2128
HP:0010907HP:0010907Abnormal circulating proline concentration0TNFRSF11B CL E G H498211909OMIM:239000Paget disease of bone 5, juvenile-onset44
HP:0010907HP:0500140Decreased circulating hydroxyproline concentration1 CL E G H
HP:0010907HP:0500139Hypoprolinemia1 CL E G H
HP:0010907HP:0008358Hyperprolinemia1ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 2HP:0040281 - Very frequent74
HP:0010907HP:0008358Hyperprolinemia1ALDH4A1 CL E G H8659406OMIM:239510Hyperprolinemia, type II.74
HP:0010907HP:0008358Hyperprolinemia1COX10 CL E G H13522260OMIM:619046MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN382
HP:0010907HP:0008358Hyperprolinemia1COX16 CL E G H5124120213OMIM:619355MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22
HP:0010907HP:0008358Hyperprolinemia1COX5A CL E G H93772267OMIM:619064MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20
HP:0010907HP:0008358Hyperprolinemia1LIPT1 CL E G H5160129569OMIM:616299Lipoyltransferase 1 deficiency21
HP:0010907HP:0008358Hyperprolinemia1NDUFB10 CL E G H47167696OMIM:619003MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35; MC1DN35
HP:0010907HP:0008358Hyperprolinemia1NDUFC2 CL E G H47187706OMIM:619170MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36
HP:0010907HP:0008358Hyperprolinemia1PDP1 CL E G H547049279ORPHA:79246Pyruvate dehydrogenase phosphatase deficiencyHP:0040282 - Frequent52
HP:0010907HP:0008358Hyperprolinemia1PRODH CL E G H56259453ORPHA:419Hyperprolinemia type 1HP:0040282 - Frequent13
HP:0010907HP:0008358Hyperprolinemia1PRODH CL E G H56259453OMIM:239500Hyperprolinemia, type I13
HP:0010907HP:0008358Hyperprolinemia1PRODH CL E G H56259453OMIM:600850Schizophrenia 413
HP:0010907HP:0008358Hyperprolinemia1SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intoleranceHP:0040282 - Frequent104
HP:0010907HP:0008358Hyperprolinemia1TARS2 CL E G H8022230740OMIM:615918Combined oxidative phosphorylation deficiency 2128
HP:0010907HP:0003260Hydroxyprolinemia1TNFRSF11B CL E G H498211909OMIM:239000Paget disease of bone 5, juvenile-onset44


Genes (12) :ALDH4A1 COX10 COX16 COX5A LIPT1 NDUFB10 NDUFC2 PDP1 PRODH SLC7A7 TARS2 TNFRSF11B

Diseases (15) :ORPHA:79101 OMIM:239510 OMIM:619046 OMIM:619355 OMIM:619064 OMIM:616299 OMIM:619003 OMIM:619170 ORPHA:79246 ORPHA:419 OMIM:239500 OMIM:600850 ORPHA:470 OMIM:615918 OMIM:239000
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.